Top Story

Bass Loses First IPR Case As PTO Rejects Acorda Therapeutics IPR Challenge

Aug 24 2015 | 7:37pm ET

The efforts of U.S. hedge fund manager Kyle Bass to utilize the patent review process as a way to challenge pharmaceutical company patents have been dealt a blow.

The U.S. Patent and Trademark office has rejected the petition challenging two Acorda Therapeutics patents on the company’s Ampyra multiple sclerosis drug. The PTO determined that Bass, whose Coalition for Affordable Drugs filed the challenge, did not present enough evidence to warrant review of the patents. 


Latest News

OppenheimerFunds Launches New Multi-Asset Growth Fund

Aug 28 2015 | 7:47pm ET

OppenheimerFunds has launched a new global multi-asset growth fund that will invest across asset classes to efficiently provide risk-adjusted growth and aims to mitigate downside risk and volatility. 

OCBC Closes on S$550M PE Fund For Asian SMEs

Aug 28 2015 | 7:32pm ET

Singapore-based OCBC Bank, has closed on a new S$550 million private equity fund launched in conjunction with its asset management subsidiary, Lion Global Investors.

Aberdeen Asset Management Launches $500M Multi-Strat Liquid Alternative Fund

Aug 28 2015 | 7:18pm ET

Aberdeen Asset Management has launched a new liquid alternatives fund that aims to offer retail investors access to a wide range of alternative investment strategies. 

ALTIN Announces 4.29% YTD Gain Through July 31

Aug 28 2015 | 6:55pm ET

Multi-strategy fund of hedge funds ALTIN has revealed first-half and July 2015 results that beat its benchmark and underlined the robustness of its fund construction. 

Senators Grassley, Cornyn Seeking Details on Litigation Finance

Aug 28 2015 | 6:38pm ET

Two Republican senators asking questions of three firms as they begin taking a serious look at a relatively new area of interest for hedge funds - litigation finance.

Fed's Bullard: Market Swings Unlikely to Sway FOMC Outlook

Aug 28 2015 | 11:59am ET

Federal Reserve Bank of St. Louis chief James Bullard has said he doesn't believe recent market turmoil will deter the FOMC from hiking interest rates this fall, since the basic economic trajectory of the United States has not changed. Bullard's comments are in marked contrast to those made recently by other senior Fed officials, including NY Fed president William Dudley.  

More News

In Depth

Malik: The Science of Deal Sourcing 201

Aug 27 2015 | 5:35pm ET

Deal sourcing is understandably a hot topic among private equity firms because it takes considerable time, energy and money to do effectively. But is courting the busiest intermediaries – i.e. those that have the most deals – the right strategy? Not necessarily, says Nadim Malik, CEO of Sutton Place Strategies, who approached this question from a quantitative perspective.

More Features
Nadim MalikNadim Malik
Don SteinbruggeDon Steinbrugge
fintech focus

Editor's Note